Paris, France-based Voluntis has received FDA marketing authorization for an algorithm-driven digital tool that helps cancer patients manage their symptoms and care teams identify clinical insights, the company announced last week.
The Oleena software is a Class II medical device that is prescribed by the patient’s care team. As the user logs their symptoms into the app, it adapts to offer...
Morristown, New Jersey-based Medocity raised $650,000, according to an SEC filing. This brings the company's total funding to at least $3 million.
The company offers providers a handful of care coordination and patient engagement programs focused on cancer care, congestive heart failure, senior care, and COPD (coming soon). The CHF and COPD programs focus on helping providers reduce readmissions...
